Giuliano Rizzardini - Infectious Diseases

Author Information

Giuliano Rizzardini is a distinguished expert in the field of infectious diseases. He is affiliated with the Department of Infectious Diseases at ASST Fatebenefratelli Sacco, located at Via G.B. Grassi 74, 20157, Milan, Italy. His work primarily focuses on understanding and addressing various infectious diseases, with a significant emphasis on viral infections and their impact on public health.

Research Contributions

Giuliano Rizzardini has made substantial contributions to the field of infectious diseases through his extensive research on topics such as COVID-19, hepatitis C virus (HCV), and malaria. In 2022, his work included pivotal studies on the implementation of HCV screening in specific birth cohorts during COVID-19 vaccination, the impact of the Omicron variant on vaccine efficacy, and investigations into long-lasting COVID-19 infections in immunocompromised patients. Additionally, he explored mortality rates among COVID-19 patients across different waves of the epidemic in Milan and conducted a budget impact analysis of the HCV patient pathway in Italy. His research efforts have significantly advanced the understanding of infectious diseases and contributed to public health strategies.

Aliases

Giuliano Rizzardini is also known by the aliases G Rizzardini and G. Rizzardini. These variations in name may appear in different publications or databases.

Publication and Citation Metrics

Metric	Value
Total Citation Count	12,665
H-Index	50
Paper Count	462

Publications:

Implementation of hcv screening in the 1969-1989 birth-cohort undergoing covid-19 vaccination: a pivotal study in Italy

DOI: 10.1016/j.dld.2022.01.071

Year: 2022

Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees’ sera: a preliminary evaluation

DOI: 10.1080/22221751.2022.2045878

Year: 2022

Viro-immunological evaluation in an immunocompromised patient with long-lasting SARS-CoV-2 infection

DOI: 10.1080/22221751.2022.2045877

Year: 2022

The value of lamp to rule out imported malaria diagnosis: a retrospective observational study in Milan, Italy

DOI: 10.1080/23744235.2021.2023754

Year: 2022

Mortality rates among COVID-19 patients hospitalised during the first three waves of the epidemic in Milan, Italy: A prospective observational study

DOI: 10.1371/journal.pone.0263548

Year: 2022

Budget Impact Analysis of HCV Patients’ Pathway: Past, Present and Future in the Italian Landscape

DOI: 10.29011/2574-3511.100072

Year: 2022

Persistence of Long-COVID symptoms in a heterogenous prospective cohort

DOI: 10.1016/j.jinf.2022.01.024

Year: 2022

Implementation of HCV screening in the 1969–1989 birth‐cohort undergoing COVID‐19 vaccination

DOI: 10.1111/liv.15216

Year: 2022

Mortality among Italians and immigrants with COVID-19 hospitalised in Milan, Italy: data from the Luigi Sacco Hospital registry

DOI: 10.1186/s12879-022-07051-9

Year: 2022

Positive predictive value of sustained virologic response 4 weeks posttreatment for achieving sustained virologic response 12 weeks posttreatment in patients receiving glecaprevir/pibrentasvir in Phase 2 and 3 clinical trials

DOI: 10.1111/jvh.13600

Year: 2021

Why is Symptomatic Relief Important?

How Does the CDC Educate the Public About Infectious Diseases?

What Are the Treatment Options for Immunodeficiency Disorders?

How are Adenoviruses Transmitted?

What Are Common Bacterial Infections?

Can Folate Biosynthesis Inhibition be Used Against All Pathogens?

How are Funds Allocated?

Why is Vaccination Essential?

What are the Key Components of HTS?

What are Antibiotics?

Partnered Content Networks

Relevant Topics